| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Criteria for the diagnosis of vascular dementia (VaD) that are reliable, valid, and readily applicable in a variety of settings are urgently needed for both clinical and research purposes. To address this need, the Neuroepidemiology Branch of the National Institute of Neurological Disorders and Stroke (NINDS) convened an International Workshop with support from the Association Internationale pour la Recherche et l'Enseignement en Neurosciences (AIREN), resulting in research criteria for the diagnosis of VaD. Compared with other current criteria, these guidelines emphasize (1) the heterogeneity of vascular dementia syndromes and pathologic subtypes including ischemic and hemorrhagic strokes, cerebral hypoxic-ischemic events, and senile leukoencephalopathic lesions; (2) the variability in clinical course, which may be static, remitting, or progressive; (3) specific clinical findings early in the course (eg, gait disorder, incontinence, or mood and personality changes) that support a vascular rather than a degenerative cause; (4) the need to establish a temporal relationship between stroke and dementia onset for a secure diagnosis; (5) the importance of brain imaging to support clinical findings; (6) the value of neuropsychological testing to document impairments in multiple cognitive domains; and (7) a protocol for neuropathologic evaluations and correlative studies of clinical, radiologic, and neuropsychological features. These criteria are intended as a guide for case definition in neuroepidemiologic studies, stratified by levels of certainty (definite, probable, and possible). They await testing and validation and will be revised as more information becomes available.
Address correspondence and reprint requests to Dr. Gustavo C. Román, Neuroepidemiology Branch, NINDS, Federal Building, Room 714, NIH, Bethesda, MD 20892.
*For Workshop participants and affiliations, see Appendix.
Received April 6, 1992. Accepted for publication in final form June 16, 1992.
This article has been cited by other articles:
|
|
 |
|
  T. L. Huang, M. C. Carlson, A. L. Fitzpatrick, L. H. Kuller, L. P. Fried, and P. P. Zandi Knee height and arm span: A reflection of early life environment and risk of dementia Neurology, May 6, 2008; 70(19_Part_2): 1818 - 1826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Sluimer, H. Vrenken, M. A. Blankenstein, N. C. Fox, P. Scheltens, F. Barkhof, and W. M. van der Flier Whole-brain atrophy rate in Alzheimer disease: Identifying fast progressors Neurology, May 6, 2008; 70(19_Part_2): 1836 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Ravaglia, P. Forti, A. Lucicesare, N. Pisacane, E. Rietti, M. Bianchin, and E. Dalmonte Physical activity and dementia risk in the elderly: Findings from a prospective Italian study Neurology, May 6, 2008; 70(19_Part_2): 1786 - 1794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Anstey, D. M. Lipnicki, and L.-F. Low Cholesterol as a Risk Factor for Dementia and Cognitive Decline: A Systematic Review of Prospective Studies With Meta-Analysis Am J Geriatr Psychiatry, May 1, 2008; 16(5): 343 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Moretti, P. Torre, R. M. Antonello, G. Cazzato, and G. Pizzolato Different Responses to Rivastigmine in Subcortical Vascular Dementia and Multi-Infarct Dementia American Journal of Alzheimer's Disease and Other Dementias, May 1, 2008; 23(2): 167 - 176. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Wiederkehr, M. Simard, C. Fortin, and R. van Reekum Comparability of the Clinical Diagnostic Criteria for Vascular Dementia: A Critical Review. Part I J Neuropsychiatry Clin Neurosci, May 1, 2008; 20(2): 150 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wiederkehr, M. Simard, C. Fortin, and R. van Reekum Validity of the Clinical Diagnostic Criteria for Vascular Dementia: A Critical Review. Part II J Neuropsychiatry Clin Neurosci, May 1, 2008; 20(2): 162 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Geerlings, T. den Heijer, P. J. Koudstaal, A. Hofman, and M.M.B. Breteler History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease Neurology, April 8, 2008; 70(15): 1258 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Kroger, R. Andel, J. Lindsay, Z. Benounissa, R. Verreault, and D. Laurin Is Complexity of Work Associated with Risk of Dementia?: The Canadian Study of Health and Aging Am. J. Epidemiol., April 1, 2008; 167(7): 820 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Feldman MD, C. Jacova PhD, A. Robillard MD, A. Garcia MD PhD, T. Chow MD, M. Borrie MB ChB, H. M. Schipper MD PhD, M. Blair BSc, A. Kertesz MD, and H. Chertkow MD Diagnosis and treatment of dementia: 2. Diagnosis Can. Med. Assoc. J., March 25, 2008; 178(7): 825 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Plassman, K. M. Langa, G. G. Fisher, S. G. Heeringa, D. R. Weir, M. B. Ofstedal, J. R. Burke, M. D. Hurd, G. G. Potter, W. L. Rodgers, et al. Prevalence of Cognitive Impairment without Dementia in the United States Ann Intern Med, March 18, 2008; 148(6): 427 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Raina, P. Santaguida, A. Ismaila, C. Patterson, D. Cowan, M. Levine, L. Booker, and M. Oremus Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline Ann Intern Med, March 4, 2008; 148(5): 379 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Gurvit, M. Emre, S. Tinaz, B. Bilgic, H. Hanagasi, H. Sahin, E. Gurol, J.T. Kvaloy, and H. Harmanci The Prevalence of Dementia in an Urban Turkish Population American Journal of Alzheimer's Disease and Other Dementias, March 1, 2008; 23(1): 67 - 76. [Abstract] [PDF]
|
|
|
|
 |
|
 Ki Woong Kim, J.-C. Youn, M.-K. Han, Nam Jong Paik, Tae Joo Lee, Joon Hyuk Park, Seok Bum Lee, Il Han Choo, Dong Young Lee, Jin Hyeong Jhoo, et al. Lack of Association Between Apolipoprotein E Polymorphism and Vascular Dementia in Koreans J Geriatr Psychiatry Neurol, March 1, 2008; 21(1): 12 - 17. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Mosconi, W. H. Tsui, K. Herholz, A. Pupi, A. Drzezga, G. Lucignani, E. M. Reiman, V. Holthoff, E. Kalbe, S. Sorbi, et al. Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias J. Nucl. Med., March 1, 2008; 49(3): 390 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Libon, C. C. Price, T. Giovannetti, R. Swenson, B. M. Bettcher, K. M. Heilman, and A. Pennisi Linking MRI Hyperintensities With Patterns of Neuropsychological Impairment: Evidence for a Threshold Effect Stroke, March 1, 2008; 39(3): 806 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Benisty, K. Hernandez, A. Viswanathan, S. Reyes, A. Kurtz, M. O'Sullivan, M.-G. Bousser, M. Dichgans, and H. Chabriat Diagnostic Criteria of Vascular Dementia in CADASIL Stroke, March 1, 2008; 39(3): 838 - 844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Swartz, D. T. Stuss, F. Gao, and S. E. Black Independent Cognitive Effects of Atrophy and Diffuse Subcortical and Thalamico-Cortical Cerebrovascular Disease in Dementia Stroke, March 1, 2008; 39(3): 822 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Libon and K. M. Heilman Assessing the Impact of Vascular Disease in Demented and Nondemented Patients Stroke, March 1, 2008; 39(3): 783 - 784. [Full Text] [PDF]
|
|
|
|
|
|
S. S. Staekenborg, W. M. van der Flier, E. C.W. van Straaten, R. Lane, F. Barkhof, and P. Scheltens Neurological Signs in Relation to Type of Cerebrovascular Disease in Vascular Dementia Stroke, February 1, 2008; 39(2): 317 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Black, J. Brandt, P. V. Rabins, Q. M. Samus, C. D. Steele, C. G. Lyketsos, and A. Rosenblatt Predictors of Providing Informed Consent or Assent for Research Participation in Assisted Living Residents Am J Geriatr Psychiatry, January 1, 2008; 16(1): 83 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. P. Almeida, G. J. Garrido, N. T. Lautenschlager, G. K. Hulse, K. Jamrozik, and L. Flicker Smoking Is Associated With Reduced Cortical Regional Gray Matter Density in Brain Regions Associated With Incipient Alzheimer Disease Am J Geriatr Psychiatry, January 1, 2008; 16(1): 92 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. Smith, S. Egorova, D. Blacker, R. J. Killiany, A. Muzikansky, B. C. Dickerson, R. E. Tanzi, M. S. Albert, S. M. Greenberg, and C. R. G. Guttmann Magnetic Resonance Imaging White Matter Hyperintensities and Brain Volume in the Prediction of Mild Cognitive Impairment and Dementia Arch Neurol, January 1, 2008; 65(1): 94 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Purandare, R C Oude Voshaar, C McCollum, A Jackson, and A Burns Paradoxical embolisation and cerebral white matter lesions in dementia Br. J. Radiol., January 1, 2008; 81(961): 30 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Bos, M. J. E. van Rijn, J. C. M. Witteman, A. Hofman, P. J. Koudstaal, and M. M. B. Breteler Incidence and Prognosis of Transient Neurological Attacks JAMA, December 26, 2007; 298(24): 2877 - 2885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Dickerson, R. A. Sperling, B. T. Hyman, M. S. Albert, and D. Blacker Clinical Prediction of Alzheimer Disease Dementia Across the Spectrum of Mild Cognitive Impairment Arch Gen Psychiatry, December 1, 2007; 64(12): 1443 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Bastos-Leite, W. M. van der Flier, E. C.W. van Straaten, S. S. Staekenborg, P. Scheltens, and F. Barkhof The Contribution of Medial Temporal Lobe Atrophy and Vascular Pathology to Cognitive Impairment in Vascular Dementia Stroke, December 1, 2007; 38(12): 3182 - 3185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J T O'BRIEN Role of imaging techniques in the diagnosis of dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S71 - S77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L BRONGE and L-O WAHLUND White matter changes in dementia: does radiology matter? Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S115 - S120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D S KNOPMAN Cerebrovascular disease and dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S121 - S127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S MILLS, J CAIN, N PURANDARE, and A JACKSON Biomarkers of cerebrovascular disease in dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S128 - S145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Borjesson-Hanson, D. Gustafson, and I. Skoog Five-year mortality in relation to dementia and cognitive function in 95-year-olds Neurology, November 27, 2007; 69(22): 2069 - 2075. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Mielke, P. B. Rosenberg, J. Tschanz, L. Cook, C. Corcoran, K. M. Hayden, M. Norton, P. V. Rabins, R. C. Green, K. A. Welsh-Bohmer, et al. Vascular factors predict rate of progression in Alzheimer disease Neurology, November 6, 2007; 69(19): 1850 - 1858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Rosenheck, D. L. Leslie, J. L. Sindelar, E. A. Miller, P. N. Tariot, K. S. Dagerman, S. M. Davis, B. D. Lebowitz, P. Rabins, J. K. Hsiao, et al. Cost-Benefit Analysis of Second-Generation Antipsychotics and Placebo in a Randomized Trial of the Treatment of Psychosis and Aggression in Alzheimer Disease Arch Gen Psychiatry, November 1, 2007; 64(11): 1259 - 1268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. M. van der Veldt, A. J. M. van den Eertwegh, K. Hoekman, F. Barkhof, and E. Boven Reversible cognitive disorders after sunitinib for advanced renal cell cancer in patients with preexisting arteriosclerotic leukoencephalopathy Ann. Onc., October 1, 2007; 18(10): 1747 - 1750. [Full Text] [PDF]
|
|
|
|
|
|
D. C. Steffens, G. G. Potter, D. R. McQuoid, J. R. MacFall, M. E. Payne, J. R. Burke, B. L. Plassman, and K. A. Welsh-Bohmer Longitudinal Magnetic Resonance Imaging Vascular Changes, Apolipoprotein E Genotype, and Development of Dementia in the Neurocognitive Outcomes of Depression in the Elderly Study Am J Geriatr Psychiatry, October 1, 2007; 15(10): 839 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kolsch, S. Larionov, O. Dedeck, M. Orantes, G. Birkenmeier, W. S. T. Griffin, and D. R. Thal Association of the Glutathione S-transferase Omega-1 Ala140Asp Polymorphism With Cerebrovascular Atherosclerosis and Plaque-Associated Interleukin-1{alpha} Expression Stroke, October 1, 2007; 38(10): 2847 - 2850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Reitz, T. den Heijer, C. van Duijn, A. Hofman, and M.M.B. Breteler Relation between smoking and risk of dementia and Alzheimer disease: The Rotterdam Study Neurology, September 4, 2007; 69(10): 998 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. Bouwman, W. M. van der Flier, N.S.M. Schoonenboom, E. J. van Elk, A. Kok, F. Rijmen, M. A. Blankenstein, and P. Scheltens Longitudinal changes of CSF biomarkers in memory clinic patients Neurology, September 4, 2007; 69(10): 1006 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ravaglia, P. Forti, F. Maioli, L. Bastagli, F. Montesi, N. Pisacane, M. Chiappelli, F. Licastro, and C. Patterson Endogenous Sex Hormones as Risk Factors for Dementia in Elderly Men and Women J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2007; 62(9): 1035 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. V. Bowler Modern concept of vascular cognitive impairment Br. Med. Bull., September 1, 2007; 83(1): 291 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schmidt, K. Petrovic, S. Ropele, C. Enzinger, and F. Fazekas Progression of Leukoaraiosis and Cognition Stroke, September 1, 2007; 38(9): 2619 - 2625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Anstey, C. von Sanden, A. Salim, and R. O'Kearney Smoking as a Risk Factor for Dementia and Cognitive Decline: A Meta-Analysis of Prospective Studies Am. J. Epidemiol., August 15, 2007; 166(4): 367 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Bastard, M. V. Buggenhout, E. D. Leenheir, J.-J. Martin, P. P. D. Deyn, and S. Engelborghs Letter to the Editor: LOW SPECIFICITY LIMITS THE USE OF THE CEREBROSPINAL FLUID AB1-42/P-TAU181P RATIO TO DISCRIMINATE ALZHEIMER'S DISEASE FROM VASCULAR DEMENTIA J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2007; 62(8): 923 - 924. [Full Text] [PDF]
|
|
|
|
|
|
M. Rentzos, G. P. Paraskevas, E. Kapaki, C. Nikolaou, M. Zoga, A. Tsoutsou, A. Rombos, and D. Vassilopoulos Circulating Interleukin-15 in Dementia Disorders J Neuropsychiatry Clin Neurosci, August 1, 2007; 19(3): 318 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. STRYDOM, G. LIVINGSTON, M. KING, and A. HASSIOTIS Prevalence of dementia in intellectual disability using different diagnostic criteria The British Journal of Psychiatry, August 1, 2007; 191(2): 150 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Auchus, H. R. Brashear, S. Salloway, A. D. Korczyn, P. P. De Deyn, C. Gassmann-Mayer, and For the GAL-INT-26 Study Group Galantamine treatment of vascular dementia: A randomized trial Neurology, July 31, 2007; 69(5): 448 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L M Allan, C G Ballard, J Allen, A Murray, A W Davidson, I G McKeith, and R A Kenny Autonomic dysfunction in dementia J. Neurol. Neurosurg. Psychiatry, July 1, 2007; 78(7): 671 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Baum, Xiangyan Chen, Wing Sze Cheung, C. K. A. Cheung, Lap Woon Cheung, K. F. P. Chiu, Hong Mei Wen, P. Poon, Kam Sang Woo, Ho Keung Ng, et al. Polymorphisms and Vascular Cognitive Impairment After Ischemic Stroke J Geriatr Psychiatry Neurol, June 1, 2007; 20(2): 93 - 99. [Abstract] [PDF]
|
|
|
|
|
|
D. Blacker, H. Lee, A. Muzikansky, E. C. Martin, R. Tanzi, J. J. McArdle, M. Moss, and M. Albert Neuropsychological Measures in Normal Individuals That Predict Subsequent Cognitive Decline Arch Neurol, June 1, 2007; 64(6): 862 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Peng, S. Xu, G. Chen, L. Wang, Y. Feng, and X. Wang l-3-n-Butylphthalide Improves Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 902 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Cohen Hypertension and Cerebral Blood Flow: Implications for the Development of Vascular Cognitive Impairment in the Elderly Stroke, June 1, 2007; 38(6): 1715 - 1717. [Full Text] [PDF]
|
|
|
|
|
|
D. Galasko, D. Salmon, A. Gamst, J. Olichney, L. J. Thal, L. Silbert, J. Kaye, P. Brooks, R. Adonay, U.-K Craig, et al. Prevalence of dementia in Chamorros on Guam: Relationship to age, gender, education, and APOE Neurology, May 22, 2007; 68(21): 1772 - 1781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Lueken, U. Seidl, L. Volker, E. Schweiger, A. Kruse, and J. Schroder Development of a Short Version of the Apathy Evaluation Scale Specifically Adapted for Demented Nursing Home Residents Am J Geriatr Psychiatry, May 1, 2007; 15(5): 376 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kaufman, D. Anaki, M. Binns, and M. Freedman Cognitive decline in Alzheimer disease: Impact of spirituality, religiosity, and QOL Neurology, May 1, 2007; 68(18): 1509 - 1514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. S.M. Reijn, M. O. Rikkert, W. J.A. van Geel, D. de Jong, and M. M. Verbeek Diagnostic Accuracy of ELISA and xMAP Technology for Analysis of Amyloid {beta}42 and Tau Proteins Clin. Chem., May 1, 2007; 53(5): 859 - 865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. V. Nunes, O. V. Forlenza, and W. F. Gattaz Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder The British Journal of Psychiatry, April 1, 2007; 190(4): 359 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
